United States Lyme Disease Diagnostics Market 2025: Industry Developments, Future Growth, Share & Industry Insights | T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Oxford Immunotec USA, Inc., Thermo Fisher Scientific

Global Lyme Disease Diagnostics Market reached USD 1.6 billion in 2022 and is expected to reach USD 2.2 billion by 2030, growing with a CAGR of 4.3% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "Lyme Disease Diagnostics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/lyme-disease-diagnostics-market?sg

Key Players: T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Oxford Immunotec USA, Inc., Thermo Fisher Scientific Inc., Quidel Corporation, Quest Diagnostics, BioMérieux India Private Limited, Diasorin S.p.A, Meridian Bioscience Inc., and Cortez Diagnostics Inc.

USA - Industry Latest News 2025:

✅ 2025-03-26 - LymeX Phase 4 launched (7 teams advanced) - U.S. LymeX Diagnostics Prize moved into Phase 4, inviting seven teams to run clinical validation and prepare regulatory submissions aimed at FDA review/clearance.

✅ 2025-07-03 - FDA clearance: new Lyme IgM / IgG immunoblots - A company announced FDA clearance for updated Lyme IgM and IgG immunoblot products intended to improve confirmatory serology.

✅ 2025-07-28 - ADLM/2025: AI-powered multiplex blood test presented / debuted - An AI-assisted multiplex assay (multiplex antigen panel + ML classifier) was presented at ADLM 2025 showing >90% sensitivity/specificity, touted as a major improvement for early detection. Several press pieces and meeting reports covered the result.

Europe - Industry Latest News 2025:

✅ 2025-(ongoing) - DiaSorin activity: LIAISON Lyme solutions / regulatory filings - DiaSorin's LIAISON® LymeDetect and related LIAISON Lyme solutions continue to be promoted in EU markets and have been under regulatory review/submission activity toward broader approvals/CLIA / automated workflows. (company materials / product pages).

✅ 2025-(throughout year) - EUROIMMUN / Mikrogen - product updates & IVDR compliance - EUROIMMUN keeps promoting its Lyme immunoassays across Europe (screening, confirmatory, CSF panels). Mikrogen also announced product updates / new assay launches and IVDR conformity work in 2025 (company press). These are incremental product-launch / compliance moves rather than single high-profile M&A.

✅ 2025-03-24 - Study flags discrepancies across widely used serological methods in Europe - A 2025 preprint/study highlighted performance differences among serologic assays, reinforcing the push for improved tests/standards in EU labs.

Growth Forecast Projected:
The Global Lyme Disease Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Lyme Disease Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=lyme-disease-diagnostics-market?sg

Key Segments:

By Test Type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test Immunofluorescent Staining, Nucleic Acid Test)

By Test Sample (Blood, Cerebrospinal Fluid, Urine)

By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Public/Private Laboratories, Physician's Office)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Lyme Disease Diagnostics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Lyme Disease Diagnostics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/lyme-disease-diagnostics-market?sg

FAQ's

Q1: What is the current size of the Lyme Disease Diagnostics Market?

A: The Lyme Disease Diagnostics Market stood at USD 1.6 billion in 2022 and is set to experience remarkable growth, reaching USD 2.2 billion by 2030

Q2: How fast is the Lyme Disease Diagnostics Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 4.3% from 2024-2031.

Q3: Which regions are dominating the Lyme Disease Diagnostics Market and which are fastest-growing?

A: North America Region Holds the Largest Market Share in the Global Lyme Disease Diagnostics Market.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/lyme-disease-diagnostics-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.